deferoxamine has been researched along with Hepatitis in 8 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Since dose-response curves were highly variable the treatment schedule should be tailored to the individual needs of each patient." | 1.26 | Iron chelation in transfusion-dependent thalassemia with chronic hepatitis. ( Cao, A; Cornacchia, G; Cossu, P; De Virgiliis, S; Frau, F; Lobrano, R; Loi, A; Loi, E; Nucaro, A; Sanna, G; Toccafondi, C, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| REWALD, E | 1 |
| UNSELD, DW | 1 |
| BARR, DG | 1 |
| FRASER, DK | 1 |
| SCHNACK, H | 1 |
| WEWALKA, F | 1 |
| De Virgiliis, S | 1 |
| Cossu, P | 1 |
| Sanna, G | 1 |
| Frau, F | 1 |
| Loi, E | 1 |
| Lobrano, R | 1 |
| Nucaro, A | 1 |
| Toccafondi, C | 1 |
| Cornacchia, G | 1 |
| Loi, A | 1 |
| Cao, A | 1 |
| Aldouri, MA | 1 |
| Wonke, B | 1 |
| Hoffbrand, AV | 1 |
| Flynn, DM | 1 |
| Laulicht, M | 1 |
| Fenton, LA | 1 |
| Scheuer, PJ | 1 |
| Kibbler, CC | 1 |
| Allwood, CA | 1 |
| Brown, D | 1 |
| Schimmelpfennig, W | 1 |
| Wagner, K | 1 |
| Schneider, G | 1 |
| Zimmermann, HB | 1 |
| Franzini, C | 1 |
| Turri, C | 1 |
| Aquili, C | 1 |
8 other studies available for deferoxamine and Hepatitis
| Article | Year |
|---|---|
SUBSTITUTIVE-INHIBITORY THERAPY IN CONSTITUTIONAL NON-SPHEROCYTIC ERYTHROCYTIC DISEASE.
Topics: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Nonspherocytic; Blood Transfusion; Deferoxa | 1964 |
[A NEW TEST ("DESFERAL TEST") FOR THE DEMONSTRATION OF PATHOLOGICAL IRON DEPOSITS IN THE ORGANISM].
Topics: Deferoxamine; Diagnosis, Differential; Hemochromatosis; Hemosiderosis; Hepatitis; Hepatitis A; Human | 1964 |
MANAGEMENT OF ACUTE IRON POISONING.
Topics: Chemical and Drug Induced Liver Injury; Deferoxamine; Hepatitis; Hepatitis A; Iron; Iron Metabolism | 1965 |
CHRONIC LIVER DISEASE AND IRON-STORAGE IN THE LIVER.
Topics: Deferoxamine; Hemochromatosis; Hepatitis; Hepatitis A; Humans; Iron; Liver Cirrhosis | 1964 |
Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Chronic Disease; Deferoxamine; Female; Fe | 1982 |
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.
Topics: Adolescent; Adult; Child; Deferoxamine; Female; Ferritins; Hepatitis; Hepatitis B Core Antigens; Hep | 1987 |
[Indications for treatment of chronic hepatitis and liver cirrhosis and their complications. 1. Treatment of chronic hepatitis and liver cirrhosis].
Topics: Azathioprine; Cholecalciferol; Chronic Disease; Deferoxamine; Glucocorticoids; Hepatitis; Humans; Li | 1974 |
[Desferrioxamine in the treatment of chronic hepatitis of the aged].
Topics: Aged; Deferoxamine; Hepatitis; Humans | 1966 |